Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de la Victoria (30)

2024

  1. Transcatheter or Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Small Aortic Annulus: A Randomized Clinical Trial

    Circulation, Vol. 149, Núm. 9, pp. 644-655

2022

  1. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

2021

  1. The clinical impact of untreated slow ventricular tachycardia in patients carrying implantable cardiac defibrillators

    Journal of Interventional Cardiac Electrophysiology, Vol. 62, Núm. 1, pp. 103-111

  2. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Complex Coronary Artery Disease

    JACC: Cardiovascular Interventions, Vol. 14, Núm. 22, pp. 2490-2499

2020

  1. Acute Coronary Syndrome Following Transcatheter Aortic Valve Replacement

    Circulation. Cardiovascular interventions, Vol. 13, Núm. 2, pp. e008620

  2. Late Cerebrovascular Events Following Transcatheter Aortic Valve Replacement

    JACC: Cardiovascular Interventions, Vol. 13, Núm. 7, pp. 872-881

  3. Transcatheter mitral repair according to the cause of mitral regurgitation: real-life data from the Spanish MitraClip registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 8, pp. 643-651

  4. Transcatheter mitral repair for functional mitral regurgitation according to left ventricular function: A real-life propensity-score matched study

    Journal of Clinical Medicine, Vol. 9, Núm. 6, pp. 1-14

2019

  1. Nutritional risk index predicts survival in patients undergoing transcatheter aortic valve replacement

    International Journal of Cardiology, Vol. 276, pp. 66-71

  2. Renin-Angiotensin System Inhibition Following Transcatheter Aortic Valve Replacement

    Journal of the American College of Cardiology, Vol. 74, Núm. 5, pp. 631-641

2018

  1. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents

    JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991

  2. Impact of preexisting left bundle branch block in transcatheter aortic valve replacement recipients

    Circulation: Cardiovascular Interventions, Vol. 11, Núm. 11

2017

  1. Clinical Impact of Baseline Right Bundle Branch Block in Patients Undergoing Transcatheter Aortic Valve Replacement

    JACC: Cardiovascular Interventions, Vol. 10, Núm. 15, pp. 1564-1574

  2. Prognostic value of body mass index in transcatheter aortic valve implantation: A “J”-shaped curve

    International Journal of Cardiology, Vol. 232, pp. 342-347

  3. Seguimiento a largo plazo de pacientes con estenosis aórtica grave tratados con prótesis autoexpandible

    Revista Espanola de Cardiologia, Vol. 70, Núm. 4, pp. 247-253

  4. Usefulness of Drug-Eluting Balloons for Bare-Metal and Drug-Eluting In-Stent Restenosis (from the RIBS IV and V Randomized Trials)

    American Journal of Cardiology, Vol. 119, Núm. 7, pp. 983-990

2016

  1. Comparison of 1-Year Outcome in Patients with Severe Aorta Stenosis Treated Conservatively or by Aortic Valve Replacement or by Percutaneous Transcatheter Aortic Valve Implantation (Data from a Multicenter Spanish Registry)

    American Journal of Cardiology, Vol. 118, Núm. 2, pp. 244-250

2015

  1. Evolución a largo plazo de pacientes cirróticos con estenosis aórtica grave tratados con implante valvular aórtico transcatéter

    Revista Espanola de Cardiologia

  2. Late cardiac death in patients undergoing transcatheter aortic valve replacement: Incidence and predictors of advanced heart failure and sudden cardiac death

    Journal of the American College of Cardiology, Vol. 65, Núm. 5, pp. 437-448

  3. New Generation CoreValve EvolutTM R 23 mm Aortic Valve Prosthesis: Initial Experience

    Revista Espanola de Cardiologia